Free Trial
NASDAQ:BTMD

biote Q1 2023 Earnings Report

biote logo
$3.35 -0.02 (-0.56%)
Closing price 03:59 PM Eastern
Extended Trading
$3.87 +0.52 (+15.49%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

biote EPS Results

Actual EPS
$0.94
Consensus EPS
$0.09
Beat/Miss
Beat by +$0.85
One Year Ago EPS
N/A

biote Revenue Results

Actual Revenue
$44.84 million
Expected Revenue
$43.38 million
Beat/Miss
Beat by +$1.46 million
YoY Revenue Growth
N/A

biote Announcement Details

Quarter
Q1 2023
Time
N/A
Conference Call Date
Tuesday, May 9, 2023
Conference Call Time
12:45PM ET

Upcoming Earnings

biote's Q2 2025 earnings is scheduled for Wednesday, May 7, 2025

biote Earnings Headlines

Biote Reports First Quarter 2025 Financial Results
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
Jefferies Reaffirms Their Buy Rating on biote (BTMD)
Marc Beer Buys Handful Of Shares In biote
See More biote Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like biote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on biote and other key companies, straight to your email.

About biote

biote (NASDAQ:BTMD) operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

View biote Profile

More Earnings Resources from MarketBeat